Metropolitan Life Insurance Company (MetLife)’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,820
| Closed | -$197K | – | 2390 |
|
|
2022
Q3 | $197K | Hold |
3,820
| – | – | 0.01% | 681 |
|
|
2022
Q2 | $94.7K | Buy |
3,820
+586
| +18% | +$14.5K | ﹤0.01% | 1085 |
|
|
2022
Q1 | $81.1K | Sell |
3,234
-11,769
| -78% | -$295K | ﹤0.01% | 1335 |
|
|
2021
Q4 | $546K | Hold |
15,003
| – | – | 0.01% | 1371 |
|
|
2021
Q3 | $257K | Hold |
15,003
| – | – | ﹤0.01% | 1897 |
|
|
2021
Q2 | $201K | Buy |
15,003
+1,197
| +9% | +$16K | ﹤0.01% | 2141 |
|
|
2021
Q1 | $707K | Sell |
13,806
-649
| -4% | -$33.3K | 0.01% | 1195 |
|
|
2020
Q4 | $895K | Buy |
14,455
+192
| +1% | +$11.9K | 0.01% | 957 |
|
|
2020
Q3 | $782K | Buy |
14,263
+655
| +5% | +$35.9K | 0.01% | 894 |
|
|
2020
Q2 | $783K | Buy |
13,608
+611
| +5% | +$35.2K | 0.01% | 891 |
|
|
2020
Q1 | $522K | Buy |
12,997
+267
| +2% | +$10.7K | 0.01% | 1023 |
|
|
2019
Q4 | $503K | Sell |
12,730
-2,251
| -15% | -$89K | 0.01% | 1322 |
|
|
2019
Q3 | $102K | Buy |
14,981
+4,873
| +48% | +$33K | ﹤0.01% | 2294 |
|
|
2019
Q2 | $94K | Buy |
10,108
+1,304
| +15% | +$12.1K | ﹤0.01% | 2336 |
|
|
2019
Q1 | $122K | Hold |
8,804
| – | – | ﹤0.01% | 2202 |
|
|
2018
Q4 | $96.1K | Buy |
8,804
+89
| +1% | +$971 | ﹤0.01% | 2302 |
|
|
2018
Q3 | $110K | Hold |
8,715
| – | – | ﹤0.01% | 2399 |
|
|
2018
Q2 | $115K | Hold |
8,715
| – | – | ﹤0.01% | 2248 |
|
|
2018
Q1 | $119K | Buy |
+8,715
| New | +$119K | ﹤0.01% | 2204 |
|
|
2016
Q1 | – | Sell |
-22,688
| Closed | -$184K | – | 2537 |
|
|
2015
Q4 | $184K | Buy |
+22,688
| New | +$184K | ﹤0.01% | 2322 |
|
|
2015
Q3 | – | Sell |
-18,968
| Closed | -$156K | – | 2708 |
|
|
2015
Q2 | $156K | Sell |
18,968
-4,454
| -19% | -$36.6K | ﹤0.01% | 2531 |
|
|
2015
Q1 | $177K | Buy |
+23,422
| New | +$177K | ﹤0.01% | 2113 |
|
|
2013
Q3 | – | Sell |
-20,609
| Closed | -$291K | – | 2777 |
|
|
2013
Q2 | $291K | Buy |
+20,609
| New | +$291K | ﹤0.01% | 2067 |
|